Beta-agonistas y el asma.

Same author

Sub-national public health intelligence responses to disease outbreaks: A mixed-methods systematic review.

Public health·2025

Same author

Culture, diversity and inclusion: a survey of British Hip Society members.

BMJ open quality·2023

Same author

Blood eosinophils: The forgotten man of inhaled steroid dose titration.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017

Same author

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

QJM : monthly journal of the Association of Physicians·2017

Same author

Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017

Same author

Histidine switch controlling pH-dependent protein folding and DNA binding in a transcription factor at the core of synthetic network devices.

Molecular bioSystems·2016

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Beta-agonistas y el asma.

Videos de Conceptos Relacionados

Sub-national public health intelligence responses to disease outbreaks: A mixed-methods systematic review.

Culture, diversity and inclusion: a survey of British Hip Society members.

Blood eosinophils: The forgotten man of inhaled steroid dose titration.

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma.

Histidine switch controlling pH-dependent protein folding and DNA binding in a transcription factor at the core of synthetic network devices.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Beta-agonistas y el asma.

Videos de Conceptos Relacionados

Artículos Relacionados

Sub-national public health intelligence responses to disease outbreaks: A mixed-methods systematic review.

Culture, diversity and inclusion: a survey of British Hip Society members.

Blood eosinophils: The forgotten man of inhaled steroid dose titration.

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma.

Histidine switch controlling pH-dependent protein folding and DNA binding in a transcription factor at the core of synthetic network devices.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.